Open image in new window Fig. 5 a & b: Electron micrographs of thyroid follicular cells of control rat (Group I).
Morphological differences were not observed in viable tumour cells of control compared to those of castrated animals (Figure 6).
In the homogenously transfected cell cultures, we found that BMP7 treatment doubled the number of apoptotic cells of control, and hTERT shRNA induced a significant cell death in parallel (Fig. 4B).
For example, exposure to 10 nM bortezomib reduced clonogenic survival to 20% (SK-N-BE 2c) cellSK-N-BE 2c(UVW/NAT SK-N-BE 2ccellsor values, whereas in the presence of 1 mM NAC, the corresponding values were 83% and 93%, respectively.
In addition, a very dynamic change in cell shape was observed in DEL cells of control embryos, but not in those of cfl1 morphants (Supplementary Movie S2).
In addition, CCR7+Foxp3+ Treg cells were detectable in the connective tissue and around the acinar or ductal cells of control salivary glands while the cells were hardly detected among the inflammatory lesions of SS patients (Fig. 5C).
Endothelial cells of control, T1D, and T1D+ESRD patients were intensely immunoreactive for Hsp27 (Figures 4B1 4B3), while in KP patients the endothelial Hsp27 immunoreactivity was moderate (Figure 4B4).
A region of the marginal deep cells from the side view was monitored during germ ring-70% epiboly stage, when active cell protrusive activity were observed in these cells of control embryos, and a 20-min movie of 10-s intervals was recorded (Fig. 6A and supplementary movie S1 and S2).
The level of ROS produced within cells of control and each treatment groups were measured by the cell permeable, non-polar, H2O2-sensitive probe 5(and 6 -chlromethyl-20,70-dichlorodihydrofluoresceindiacetate (CM-H2DCFDA; Sigma, USA) by the method described previously [38].
Since T cells were our main interest we added more patients with the same characteristics of the microarray patients (Table 1) to verify differences at the protein level; the results show a significantly higher expression of CD46 on T cells of control patients, without variation on macrophages or neutrophils (Fig. 1A), this data is further supported by the in vivo experiments.
